Federation des caisses Desjardins du Quebec’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.58M Sell
8,038
-11,336
-59% -$5.05M 0.02% 474
2025
Q1
$9.39M Sell
19,374
-33,862
-64% -$16.4M 0.05% 240
2024
Q4
$21.4M Buy
53,236
+13,749
+35% +$5.54M 0.11% 152
2024
Q3
$18.4M Sell
39,487
-13,701
-26% -$6.37M 0.09% 162
2024
Q2
$24.9M Buy
53,188
+5,581
+12% +$2.62M 0.13% 131
2024
Q1
$19.8M Sell
47,607
-97
-0.2% -$40.4K 0.14% 143
2023
Q4
$19.4M Buy
47,704
+1,306
+3% +$531K 0.18% 127
2023
Q3
$16.1M Buy
46,398
+42,004
+956% +$14.6M 0.17% 127
2023
Q2
$1.55M Sell
4,394
-3,787
-46% -$1.33M 0.02% 491
2023
Q1
$2.58M Buy
8,181
+2,993
+58% +$943K 0.03% 346
2022
Q4
$1.5M Buy
5,188
+43
+0.8% +$12.4K 0.02% 450
2022
Q3
$1.49M Buy
5,145
+336
+7% +$97.3K 0.02% 455
2022
Q2
$1.36M Sell
4,809
-1,404
-23% -$396K 0.02% 485
2022
Q1
$1.62M Buy
6,213
+165
+3% +$43.1K 0.02% 493
2021
Q4
$1.33M Sell
6,048
-537
-8% -$118K 0.01% 571
2021
Q3
$1.19M Buy
6,585
+71
+1% +$12.9K 0.01% 639
2021
Q2
$1.31M Buy
6,514
+1,116
+21% +$225K 0.01% 627
2021
Q1
$1.16M Buy
5,398
+1,527
+39% +$328K 0.01% 636
2020
Q4
$915K Buy
3,871
+3,213
+488% +$760K 0.01% 659
2020
Q3
$179K Buy
658
+154
+31% +$41.9K ﹤0.01% 904
2020
Q2
$146K Sell
504
-92
-15% -$26.7K ﹤0.01% 920
2020
Q1
$142K Buy
596
+350
+142% +$83.3K ﹤0.01% 944
2019
Q4
$53.9K Buy
246
+124
+102% +$27.2K ﹤0.01% 1496
2019
Q3
$20.7K Hold
122
﹤0.01% 1668
2019
Q2
$22.4K Sell
122
-399
-77% -$73.2K ﹤0.01% 1670
2019
Q1
$95.8K Sell
521
-32
-6% -$5.89K ﹤0.01% 1158
2018
Q4
$91.6K Buy
553
+104
+23% +$17.2K ﹤0.01% 1144
2018
Q3
$86.5K Sell
449
-23
-5% -$4.43K ﹤0.01% 1214
2018
Q2
$80.2K Sell
472
-350
-43% -$59.5K ﹤0.01% 1234
2018
Q1
$134K Buy
822
+152
+23% +$24.8K ﹤0.01% 1113
2017
Q4
$100K Sell
670
-7,856
-92% -$1.18M ﹤0.01% 1168
2017
Q3
$1.3M Buy
8,526
+5,031
+144% +$766K 0.02% 548
2017
Q2
$450K Buy
3,495
+3,485
+34,850% +$449K 0.01% 746
2017
Q1
$1.09K Buy
+10
New +$1.09K ﹤0.01% 1693